Shares of e-therapeutics plc (LON:ETX – Get Rating) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 18.31 ($0.22) and traded as low as GBX 14.92 ($0.18). e-therapeutics shares last traded at GBX 15.50 ($0.19), with a volume of 13,321 shares.
e-therapeutics Stock Performance
The firm has a fifty day simple moving average of GBX 16.80 and a 200-day simple moving average of GBX 18.31. The company has a market cap of £90.23 million, a PE ratio of -775.00 and a beta of 0.56. The company has a quick ratio of 20.13, a current ratio of 22.64 and a debt-to-equity ratio of 2.03.
Insiders Place Their Bets
In related news, insider Trevor Mervyn Jones purchased 44,350 shares of the stock in a transaction that occurred on Wednesday, January 4th. The shares were purchased at an average price of GBX 17 ($0.21) per share, with a total value of £7,539.50 ($9,097.98). Corporate insiders own 62.63% of the company’s stock.
e-therapeutics Company Profile
e-Therapeutics plc engages in drug discovery research activities in the United Kingdom. Its computational platform provides in silico screens generate predictions on compounds and/or targets that can have a significant perturbative effect on the biology of interest, captured by its network models, as well as developing RNAi platform for highly specific gene silencing.
- The 3 Most Upgraded Stocks Are Reversing
- How to Find Blue Chip Dividend Stocks
- Zscaler, Inc Plummets, Is It Time To Buy The Dip?
- What is a Good Dividend Yield? How to Decide
- Taiwan Semiconductor Manufacturing Expanding in the West
Receive News & Ratings for e-therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for e-therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.